CGS vs LDX

ASX Healthcare sector comparison — updated 3 Sep 2026 — Healthcare sector

CGS

COGSTATE FPO [CGS]

57MEDIUM

LDX

LUMOS FPO [LDX]

56MEDIUM

Score Breakdown

CGS LDX
Technical
61
43
Catalyst
55
51
Sentiment
50
50
Fundamental
99
76
Momentum
64
47
Risk Gate
45
50

Key Metrics

CGS Metric LDX
$523.4MMarket Cap$91.6M
699KAvg Volume (20d)937K
+0.0%Short InterestN/A
$3.23052-Week High$0.330
$1.69052-Week Low$0.076
-0.3%Daily Change-3.0%
$3.070Reference Price$0.097
+22.5%ROE-34.1%
+19.5%Profit Margin-37.5%

Active Signals

CGS Signals

●Beating the Small Ords index — relative strength of 1.21, so it's outpacing the pack
●Trading above the 200-day average — the long-term trend is on your side
●Cash positive / operating cashflow positive
●Moderate P/S ratio (8.6x)
●Moderate revenue growth (+16%)
●Piotroski F-Score strong (8/9, low-confidence approx)
●EPS estimates revised upward (+10pts)
●Near 52-week high (90% of range)

LDX Signals

●RSI drifting toward oversold territory — worth watching
●MACD momentum is losing steam
●Stochastic is deep in oversold territory — bounce conditions forming
●Trading below both moving averages — the trend is working against this one
●Sitting near support — this level has held before and could attract buyers again
●Lagging the Small Ords index — relative strength of 0.79, underperforming its peers
●Volatility is contracting — like a spring being compressed, breakouts often follow
●Below the 200-day average — the long-term trend is still working against it

Ask Scout AI to compare CGS and LDX in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener

Related Comparisons

CGS vs LGP →EYE vs SOM →NOX vs RHT →LDX vs SPL →BLS vs SPL →
CGS Full Analysis → LDX Full Analysis → Healthcare Sector → All Comparisons →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).